Stocks to buy: Galaxy Surfactants, Mankind Pharma and Engineers India; check share price target by Axis, rationale
Indian markets moved lower.
· LiveMint Markets
The Nifty 50 ended the week at 22,422, marking an extended decline. Immediate support lies at 22,200. Key recommendations include Galaxy Surfactants, Mankind Pharma, and Engineers India, each presenting potential profits in the coming weeks, according to Axis Direct's analysis.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Stock Market Crash LIVE: Sensex Tanks Over 1,200 Points, Nifty 50 Below 22,200; ITC, JSW Steel, IndiGo Among Top Losers
INR vs USD: Rupee near 97/dollar; how TCS, Sun Pharma, Tata Steel, SRF may gain from weaker currency? Experts explain
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Valiant Organics among 5 commodity stocks that hit 52-week highs and rallied up to 48% in a month